Nasdaq: IOVA

Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker IOVA. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
IOVA
Exchange
Nasdaq
SEC CIK
1425205
Official filings
SEC EDGAR

Research IOVA

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Iovance Biotherapeutics, Inc.'s stock ticker?

Iovance Biotherapeutics, Inc. trades under the ticker symbol IOVA on Nasdaq. Its SEC Central Index Key (CIK) is 1425205.

Where can I read Iovance Biotherapeutics, Inc.'s SEC filings?

The IOVA SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Iovance Biotherapeutics, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze IOVA's financial statements?

The IOVA Financials page shows Iovance Biotherapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does IOVA compare with its peers and the market?

The IOVA Peer Comparison page lines Iovance Biotherapeutics, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.